All In Biotech

Drug Trial Radar · NCT05593614

Efficacy and Safety of ATX01 in Adult Patients With CIPN (Chemotherapy-induced Peripheral Neuropathy)

A Multicenter, Randomized, Double-blind, Parallel-group, Placebo-controlled, Phase 2 Study to Assess the Efficacy and Safety of ATX01 (Topical Amitriptyline Hydrochloride 10% and 15% w/w) in Comparison to Placebo, in Cancer Survivor Adult Patients With Chemotherapy-induced Peripheral Neuropathy (CIPN)

Last checked: Nov 19, 2026Latest source record: Jul 16, 2024 (this record)Source: ClinicalTrials.govMethods & limitations

Active, not recruitingPivotal-lookingRandomized with 276 participants. This is a heuristic, not a regulatory label.

Status

Active, not recruiting

Enrollment

276

Actual

Start

Feb 28, 2023

Primary completion

Sep 2024

Study completion Sep 2024

Sponsor

Lead sponsor
AlgoTherapeutixIndustry
Sponsor type
Industry
First posted
Oct 25, 2022

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this clinical trial is to compare the efficacy of twice daily applications of ATX01 (10% \& 15%) versus placebo during a 12-week treatment period in treating chemotherapy-induced peripheral neuropathy (CIPN) in adult cancer survivor patients.

Conditions

  • Chemotherapy-induced Peripheral Neuropathy

Interventions

  • ATX01 10%Drug

    A 100 mL bottle of hydrogel formulation containing 10% amitriptyline hydrochloride w/w

  • ATX01 15%Drug

    A 100 mL bottle of hydrogel formulation containing 15% amitriptyline hydrochloride w/w

  • PlaceboDrug

    A 100 mL bottle of hydrogel formulation containing no active substance

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Change from baseline to Week 12 in the weekly mean of the daily NPRS score assessing average pain intensity in target study extremities related to CIPN in the past 24 hours.Time frame: 12 weeks

Locations

43 sites in 7 countries. Site status is shown where the registry gives one.

  • South Lake Pain Institute

    Clermont, Florida

  • MGM Medical Care Research & Rehab, LLC

    Miami, Florida

  • Medsol Clinical Research Center, Inc

    Port Charlotte, Florida

  • Knight Neurology - Clinical Research

    Rockledge, Florida

  • Neuroscience Research Center, LLC.

    Overland Park, Kansas

  • The Center for Cancer and Blood Disorders (CCBD)

    Bethesda, Maryland

  • University of Rochester Medical Center

    Rochester, New York

  • HD Research

    Bellaire, Texas

  • OLV Hospital Aalst: gastro-enterologie

    Aalst, Belgium

  • Universitair Ziekenhuis Antwerpen

    Edegem, Belgium

  • Universitair Ziekenhuis Gent (UZ Gent)

    Ghent, Belgium

  • UZ Leuven / Campus Pellenberg / Pain Center

    Pellenberg, Belgium

  • CHU UCL Namur - site Godinne

    Yvoir, Belgium

  • Clinitrial s.r.o.

    Prague, Czechia

  • Praglandia s.r.o.

    Prague, Czechia

  • Nemocnice Teplice

    Teplice, Czechia

  • Centre Hospitalier de la Côte Basque

    Bayonne, France

  • Institute Bergonie

    Bordeaux, France

  • CHU de Montpellier, Hôpital Saint Eloi

    Montpellier, France

  • Groupe Hospitalier Paris Saint Joseph

    Paris, France

  • CHU POITIERS, Hépato-Gastro Entérologie

    Poitiers, France

  • GODINOT Institute

    Reims, France

  • Strasbourg Oncologie Liberale

    Strasbourg, France

  • Hôpital Foch

    Suresnes, France

  • Gemelli Molise S.p.a.

    Campobasso, Italy

  • Istituto Scientifico Romagnolo per lo Studio e La cura dei Tumori Srl (IRST)

    Meldola, Italy

  • Fondazione IRCCS Ca' Granda Ospedale -. Maggiore Policlinico

    Milan, Italy

  • ASST Monza - Ospedale S. Gerardo di Monza

    Monza, Italy

  • Fondazione IRCCS Policlinico San Matteo - Universita degli Studi di Pavia

    Pavia, Italy

  • Azienda Ospedaliera San Camillo-Forlanini

    Roma, Italy

  • Przychodnia Lekarska "Komed" Roman Karaszewski Oddzial Chemioterapii Jednego Dnia

    Konin, Poland

  • Instytut "Centrum Zdrowia Matki Polki" Klinika Onkologii

    Lodz, Poland

  • Niepubliczny Zaklad Opieki Zdrowotnej Poradnia Leczenia Bolu Przewleklego

    Tychy, Poland

  • ClinHouse sp z o.o. - ClinHouse Centrum Medyczne

    Zabrze, Poland

  • Hospital de la Santa Creu I de Sant Pau

    Barcelona, Spain

  • Hospital Universitari de Bellvitge

    Barcelona, Spain

  • Hospital Universitario Reina Sofia

    Córdoba, Spain

  • Complejo Hospitalarion de Jaen

    Jaén, Spain

  • Hospital General Universitario Gregorio Maranon

    Madrid, Spain

  • Hospital Ruber Internacional

    Madrid, Spain

Showing 40 of 43 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.